NA
Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: An effective but still broken option / Ricciuti B.; Lamberti G.; Roila F.; Metro G.. - In: TRANSLATIONAL LUNG CANCER RESEARCH. - ISSN 2218-6751. - STAMPA. - 8:S4(2019), pp. S378-S382. [10.21037/tlcr.2019.04.15]
Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: An effective but still broken option
Ricciuti B.;Lamberti G.Writing – Original Draft Preparation
;
2019
Abstract
NAFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
